The last three decades have provided opportunities to explore the potential of treating malignant diseases with antibodies or other targeting molecules labelled with nuclides. The expanding array of new targeting molecules (recombinant antibodies or peptides) may increase the therapeutic efficacy. T...
|Main Author:||Stigbrand, Torgny.|
|Corporate Author:||SpringerLink (Online service)|
|Other Authors:||Carlsson, Jörgen., Adams, Gregory P.|
Connect to electronic text
No Tags, Be the first to tag this record!